Neuromodulation of frontal and temporal cortex by intravenous d-fenfluramine: An [15O]H2O PET study in humans

Neuroscience Letters

Volumn 207, Issue 1, 1996, Pages 25-28

  Meyer, Jeffrey H ^a   Kapur, Shitij ^a   Wilson, Alan A ^a   DaSilva, Jean N ^a   Houle, Sylvain ^a   Brown, Gregory M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Fenfluramine; Frontal cortex; Positron emission tomography; Serotonin; Temporal cortex; Thalamus

Indexed keywords

DEXFENFLURAMINE; SEROTONIN AGONIST;

ADULT; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; TEMPORAL CORTEX; THALAMUS;

ADULT; ANIMALS; BEHAVIOR; FEMALE; FENFLURAMINE; FRONTAL LOBE; GROWTH HORMONE; HUMANS; HYDROCORTISONE; OXYGEN RADIOISOTOPES; SEROTONIN AGENTS; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0029969435     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12479-4     Document Type: Article

References (22)

1. Bailey, D.L., Jones, T., Friston, K.J., Colebatch, J.G. and Frackowiak, R.S.J., Physical validation of statistical parametric mapping, J. Cereb Blood Flow Metab., 11 (1991) 1-8.
2. Bond, A.J., Feizollah, S. and Lader, M.H., The effects of d-fenfluramine on mood and performance, and on neuroendocrine indicators of 5-HT function, J. Psychopharmacol., 9 (1995) 1-8.
3. Casaneuva, F.F., Villanueva, L., Penalva, A. and Cabezas-Cerrato, J., Depending on the stimulus, central serotonergic activation by fenfluramine blocks or does not alter growth hormone secretion in man, Neuroendocrinology, 38 (1984) 302-308.
4. Friston, K.J., Frith, C.D., Liddle, P.F. and Frackowiak, R.S., Comparing functional (PET) images: the assessment of significant change, J. Cereb. Blood Flow Metab., 4 (1991) 690-699.
5. Friston, K.J., Holmes, A.P., Worsley, K.J., Poline, J.P., Frith, C.D. and Frackowiak, R.S.J., Statistical parametric maps in functional imaging: a general approach, Hum. Brain Mapping, 2 (1995) 189-210.
6. Goldman-Rakic, P.S., Topography of cognition: parallel distributed networks in primate association cortex, Ann. Rev. Neurosci., 11 (1988) 137-156.
7. Goyer, P.F., Semple, W.E. and Morris, E.D., Effects of MK-212 on regional cerebral blood flow in humans, Schizophrenia Res., 9 (1993) 199.
8. Grunberger, J., Saletu, B., Linzmayer, L. and Barbanoj, M.J., Clinical-Pharmacological study with two isomers (d-,l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: psychometric and psychophysiological evaluation, Methods Find. Exp. Clin. Pharmacol., 15 (1993) 313-328.
9. 1D binding sites, Br. J. Pharmacol., 102 (1991) 227-233.
10. Hamilton, M., A rating scale for depression, J. Neurol. Neurosurg. Psychiatry, 23 (1960) 56-62.
11. Jansen, I., Olesen, J. and Edvinsson, I., 5-Hydroxytryptamine receptor characterization of human cerebral, middle meningeal and temporal arteries: regional differences, Acta Physiol. Scand., 147 (1993) 141-150.
12. Kapur, S., Meyer, J., Wilson, A.A., Houle, S. and Brown, G.M., Modulation of cortical neuronal activity by a serotonergic agent: a PET study in humans, Brain Res., 646 (1994) 292-294.
13. 2O PET study in humans, Neurosci. Lett., 176 (1994) 21-24.
14. Murphy, D.L., Mueller, E.A., Hill, J.L., Tolliver, T.J. and Jacobsen, F.M., Comparative anxiogenic, neuroendocrine and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers, Psychopharmacology, 16 (1989) 471-478.
15. O'Keane, V., O'Hanlon, M., Webb, M. and Dinan, T., d-Fenfluramine response throughout the menstrual cycle: evidence for an oestrogen-induced alteration, Clin. Endocrinol., 34 (1991) 289-292.
16. 1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery, Br. J. Pharmacol., 96 (1989) 434-449.
17. Quattrone, A., Tedeschi, G., Aguglia, U., Scopacasa, F., Di Renzo, G.F. and Annunziato, L., Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones; studies with fenfluramine, Br. J. Clin. Pharmacol., 16 (1983) 471-478.
18. Saletu, B., Barbanoj, M.J., Anderer, P., Sighart, W. and Grunberger, J., Clinical-pharmacological study with the two isomer (d-,l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: blood levels, EEG mapping and safety evaluation, Methods Find. Exp. Clin. Pharmacol., 5 (1993) 291-312.
19. Spitzer, R.L., Williams, J.B.W., Gibbon, M. and First, M.B., Structured Clincial Interview for DSM-III-R: Patient Edition (SCID-P, Version 1.0), American Psychiatric Press, Washington, DC, 1990.
20. Talairach, J. and Tournoux, P., Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System, an Approach to Cerebral Imaging, Georg Thieme, Stuttgart, 1988.
21. Van Kammen, D.P. and Murphy, D.L., Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment, Psychopharmacologia, 44 (1975) 215-224.
22. Yatham, L. and Steiner, M., Neuroendocrine probes of serotonergic function: a critical review, Life Sci., 53 (1993) 447-463.